Certara alternatives
Companies similar to Certara on cro.directory, ranked by shared capabilities and locations focusing on Vaccine, Cell Therapy, Gene Therapy, and Antibody-Drug Conjugate (ADC). Below are the top 10 cros with overlapping structured profile data.
Shares Clinical Trial Services, China NMPA Regulatory Strategy, Japan PMDA Regulatory Strategy, and EU EMA Regulatory Strategy.
Shares Clinical Trial Services, China NMPA Regulatory Strategy, Japan PMDA Regulatory Strategy, and EU EMA Regulatory Strategy.
Shares Clinical Trial Services, US FDA Regulatory Strategy, Phase IV / Post-Marketing, and Clinical Operations.
Shares China NMPA Regulatory Strategy, Japan PMDA Regulatory Strategy, EU EMA Regulatory Strategy, and US FDA Regulatory Strategy.
Shares Clinical Trial Services, China NMPA Regulatory Strategy, Japan PMDA Regulatory Strategy, and EU EMA Regulatory Strategy.
Shares Clinical Trial Services, US FDA Regulatory Strategy, Clinical Operations, and Phase III Clinical Trials.
Shares Clinical Trial Services, US FDA Regulatory Strategy, Phase IV / Post-Marketing, and Clinical Operations.
Shares EU EMA Regulatory Strategy, US FDA Regulatory Strategy, Phase IV / Post-Marketing, and Clinical Operations.
Shares Clinical Trial Services, China NMPA Regulatory Strategy, Japan PMDA Regulatory Strategy, and EU EMA Regulatory Strategy.
Shares Clinical Trial Services, US FDA Regulatory Strategy, Phase IV / Post-Marketing, and Clinical Operations.
How we pick similar companies: alternatives similarity uses shared services, modalities, locations, and site-specific capability fields — not sponsorship. Missing fields stay blank. Data comes from structured directory profiles.
Interactive comparison
Lock shared capabilities to filter peers. Locked views are not indexed — the canonical page stays unlocked.
Capability locks
- WuXi AppTec
Shares Clinical Trial Services, China NMPA Regulatory Strategy, Japan PMDA Regulatory Strategy, and EU EMA Regulatory Strategy.
- Tigermed
Shares Clinical Trial Services, China NMPA Regulatory Strategy, Japan PMDA Regulatory Strategy, and EU EMA Regulatory Strategy.
- Protheragen
Shares Clinical Trial Services, US FDA Regulatory Strategy, Phase IV / Post-Marketing, and Clinical Operations.
- Aragen Life Sciences
Shares China NMPA Regulatory Strategy, Japan PMDA Regulatory Strategy, EU EMA Regulatory Strategy, and US FDA Regulatory Strategy.
- Premier Research
Shares Clinical Trial Services, China NMPA Regulatory Strategy, Japan PMDA Regulatory Strategy, and EU EMA Regulatory Strategy.
- Frontage Laboratories
Shares Clinical Trial Services, US FDA Regulatory Strategy, Clinical Operations, and Phase III Clinical Trials.
- QPS
Shares Clinical Trial Services, US FDA Regulatory Strategy, Phase IV / Post-Marketing, and Clinical Operations.
- Labcorp
Shares EU EMA Regulatory Strategy, US FDA Regulatory Strategy, Phase IV / Post-Marketing, and Clinical Operations.
- Medpace
Shares Clinical Trial Services, China NMPA Regulatory Strategy, Japan PMDA Regulatory Strategy, and EU EMA Regulatory Strategy.
- Allucent
Shares Clinical Trial Services, US FDA Regulatory Strategy, Phase IV / Post-Marketing, and Clinical Operations.
Markdown mirror: /alternatives/certara.md